Everence Capital Management’s NeoGenomics NEO Stock Holding History

Everence Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,530	Closed	-$244K	–	962
2024 Q3	$244K	Sell	16,530 -1,310	-7%	-$20.5K	0.02%	665
2024 Q2	$248K	Hold	17,840	–	–	0.02%	604
2024 Q1	$280K	Hold	17,840	–	–	0.02%	589
2023 Q4	$289K	Hold	17,840	–	–	0.02%	569
2023 Q3	$219K	Hold	17,840	–	–	0.02%	635
2023 Q2	$306K	Hold	17,840	–	–	0.02%	517
2023 Q1	$311K	Hold	17,840	–	–	0.03%	525
2022 Q4	$165K	Hold	17,840	–	–	0.01%	720
2022 Q3	$154K	Hold	17,840	–	–	0.01%	686
2022 Q2	$145K	Hold	17,840	–	–	0.01%	689
2022 Q1	$217K	Hold	17,840	–	–	0.02%	666
2021 Q4	$609K	Hold	17,840	–	–	0.05%	347
2021 Q3	$861K	Hold	17,840	–	–	0.07%	228
2021 Q2	$806K	Hold	17,840	–	–	0.07%	238
2021 Q1	$860K	Sell	17,840 -2,430	-12%	-$127K	0.08%	209
2020 Q4	$1.09M	Sell	20,270 -1,930	-9%	-$87.2K	0.11%	160
2020 Q3	$819K	Buy	22,200 +3,310	+18%	+$123K	0.09%	180
2020 Q2	$504K	Hold	18,890	–	–	0.06%	294
2020 Q1	$522K	Hold	18,890	–	–	0.07%	228
2019 Q4	$553K	Hold	18,890	–	–	0.08%	261
2019 Q3	$361K	Hold	18,890	–	–	0.06%	368
2019 Q2	$414K	Hold	18,890	–	–	0.07%	318
2019 Q1	$386K	Buy	+18,890	New	+$328K	0.07%	327

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Everence Capital Management's NEO Position: Q4 2024 in Review

Everence Capital Management sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 16,530 shares — an estimated $244K sold.

Everence Capital Management first reported a position in NEO in Q1 2019 and held it in 23 quarters. The position peaked at $1.09M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

Everence Capital Management reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
Everence Capital Management sold 16,530 NeoGenomics shares in Q4 2024, an estimated $244K.
Everence Capital Management first reported a position in NeoGenomics in Q1 2019 and held it in 23 quarters.
Everence Capital Management's NeoGenomics position peaked at $1.09M in Q4 2020.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.